US 11,850,440 B2
Therapeutic systems using magnetic fields
Calvin S. Carter, Iowa City, IA (US); Sunny C. Huang, Iowa City, IA (US); Michael J. Miller, Iowa City, IA (US); Charles C. Searby, Iowa City, IA (US); and Val C. Sheffield, Iowa City, IA (US)
Assigned to University of Iowa Research Foundation, Iowa City, IA (US)
Filed by University of Iowa Research Foundation, Iowa City, IA (US)
Filed on Aug. 19, 2020, as Appl. No. 16/947,824.
Claims priority of provisional application 62/890,372, filed on Aug. 22, 2019.
Prior Publication US 2021/0052910 A1, Feb. 25, 2021
Int. Cl. A61N 2/00 (2006.01); A61N 2/02 (2006.01); A61N 2/06 (2006.01)
CPC A61N 2/004 (2013.01) [A61N 2/02 (2013.01); A61N 2/06 (2013.01)] 8 Claims
OG exemplary drawing
 
1. A method, comprising:
identifying a subject having metabolic dysfunction or aberrant reactive oxygen species, reactive nitrogen species or oxidative stress;
delivering a therapy to the subject to treat the metabolic dysfunction or the aberrant reactive oxygen species, reactive nitrogen species or oxidative stress by delivering energy to tissue, wherein delivering energy to the tissue includes:
providing at least one magnetic field in a first direction to the tissue and in a second direction to the tissue using at least one magnetic field system including at least one magnetic field source to produce the at least one magnetic field, wherein the magnetic field produced by the magnetic field source includes a magnetic field produced by at least one of a permanent magnet, a temporary magnet or electric current flow through a conductor, wherein the second direction is non-parallel to the first direction.